$0.81
-0.0183[-2.21%]
Last update: 7:10PM Get Real Time Here
Viracta Therapeutics: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Feb 27, 2024 | Daniel Chevallard | CFO AND COO | 3.484K | $0.73 | -$2.49K | SELL-OPTIONS | 3.53% | 102.306K | Feb 25 - Feb 27 | View |
Dec 04, 2023 | Mark Rothera | PRESIDENT AND CEO | 100K | $0.49 | $49.36K | BUY | ∞ | 100K | Nov 30 - Dec 01 | View |
Nov 28, 2023 | Daniel Chevallard | CFO AND COO | 3.169K | $0.50 | -$1.86K | SELL-OPTIONS | 3.31% | 98.822K | Nov 25 - Nov 28 | View |
Aug 29, 2023 | Daniel Chevallard | CFO AND COO | 3.376K | $1.45 | -$5.09K | SELL-OPTIONS | 3.66% | 95.653K | Aug 25 - Aug 28 | View |
May 26, 2023 | Daniel Chevallard | CFO AND COO | 3.254K | $1.42 | -$5.16K | SELL-OPTIONS | 3.66% | 92.277K | May 25 | View |
Feb 28, 2023 | Lisa Rojkjaer | CHIEF MEDICAL OFFICER | 1.971K | $1.68 | -$3.62K | SELL-OPTIONS | 4.27% | 48.087K | Feb 25 - Feb 27 | View |
Feb 28, 2023 | Daniel Chevallard | CFO AND COO | 3.29K | $1.68 | -$6.05K | SELL-OPTIONS | 3.84% | 89.023K | Feb 25 - Feb 27 | View |
Nov 29, 2022 | Daniel Chevallard | CFO AND COO | 3.357K | $2.72 | -$9.61K | SELL-OPTIONS | 4.08% | 85.733K | Nov 25 - Nov 28 | View |
Nov 29, 2022 | Lisa Rojkjaer | CHIEF MEDICAL OFFICER | 2.011K | $2.72 | -$5.75K | SELL-OPTIONS | 4.56% | 46.116K | Nov 25 - Nov 28 | View |
Aug 29, 2022 | Lisa Rojkjaer | CHIEF MEDICAL OFFICER | 1.937K | $4.01 | -$8.79K | SELL-OPTIONS | 4.59% | 44.105K | Aug 25 - Aug 26 | View |
Aug 29, 2022 | Daniel Chevallard | CFO AND COO | 3.234K | $4.02 | -$14.68K | SELL-OPTIONS | 4.09% | 82.376K | Aug 25 - Aug 26 | View |
Aug 29, 2022 | IVOR ROYSTON | CEO & PRESIDENT | 11.84K | $4.01 | -$53.66K | SELL-OPTIONS | 1.91% | 631.369K | Aug 25 - Aug 26 | View |
May 27, 2022 | IVOR ROYSTON | CEO & PRESIDENT | 12.057K | $1.90 | -$25.02K | SELL-OPTIONS | 1.98% | 619.529K | May 25 - May 26 | View |
May 27, 2022 | Lisa Rojkjaer | CHIEF MEDICAL OFFICER | 1.973K | $1.90 | -$4.09K | SELL-OPTIONS | 4.91% | 42.168K | May 25 - May 26 | View |
May 27, 2022 | Daniel Chevallard | CFO AND COO | 3.293K | $1.90 | -$6.84K | SELL-OPTIONS | 4.34% | 79.142K | May 25 - May 26 | View |
Mar 01, 2022 | IVOR ROYSTON | CEO & PRESIDENT | 10.584K | $2.78 | -$40.68K | SELL-OPTIONS | 1.77% | 607.472K | Feb 25 - Feb 28 | View |
Mar 01, 2022 | Lisa Rojkjaer | CHIEF MEDICAL OFFICER | 1.732K | $2.78 | -$6.66K | SELL-OPTIONS | 4.50% | 40.195K | Feb 25 - Feb 28 | View |
Mar 01, 2022 | Daniel Chevallard | CFO AND COO | 2.891K | $2.78 | -$11.11K | SELL-OPTIONS | 3.96% | 75.849K | Feb 25 - Feb 28 | View |
Nov 29, 2021 | Lisa Rojkjaer | CHIEF MEDICAL OFFICER | 3.713K | $4.81 | -$21.85K | SELL-OPTIONS | 10.68% | 38.463K | Nov 25 - Nov 29 | View |
Browse insider trades on all stocks.